Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 6.35
-0.10 (-1.55%)
At close: Jul 17, 2026
Labiana Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2.57 | 0.25 | -4.42 | -8.94 | -1.78 |
Depreciation & Amortization | 3.79 | 2.13 | 2.59 | 2.71 | 2.55 |
Other Amortization | - | 2.12 | 2.49 | 2.12 | 2.46 |
Loss (Gain) From Sale of Assets | - | -0.12 | 0.02 | - | - |
Asset Writedown & Restructuring Costs | 0.75 | 0.95 | 0.06 | 3.54 | 0.42 |
Other Operating Activities | -3.11 | -1.24 | -1 | 0.91 | -1.43 |
Change in Accounts Receivable | -1.31 | 2.86 | -1.64 | -0.82 | 3.14 |
Change in Inventory | -2.56 | -1.2 | 1.12 | 1.09 | -0.85 |
Change in Accounts Payable | 1.64 | 1.56 | -1.96 | 4.28 | -0.61 |
Change in Other Net Operating Assets | -0.08 | -0.12 | 0.91 | -0.22 | 0 |
Operating Cash Flow | 1.7 | 7.19 | -1.83 | 4.68 | 3.91 |
Operating Cash Flow Growth | -76.37% | - | - | 19.76% | 3.10% |
Capital Expenditures | -4.36 | -3.02 | -1.66 | -2.78 | -2.3 |
Sale of Property, Plant & Equipment | - | 0 | 0.02 | - | - |
Cash Acquisitions | - | -0.04 | - | - | -1.1 |
Divestitures | - | - | - | - | 2.36 |
Sale (Purchase) of Intangibles | -0.08 | -0.03 | -0.88 | -2.67 | -2.47 |
Investment in Securities | 0.2 | -0.9 | 0.49 | 2.51 | -3.72 |
Investing Cash Flow | -4.24 | -3.99 | -2.03 | -2.95 | -7.23 |
Long-Term Debt Issued | 4.25 | 4.37 | 19.55 | 0.74 | 8.74 |
Long-Term Debt Repaid | -2.74 | -3.64 | -16.35 | -7.41 | -2.56 |
Net Debt Issued (Repaid) | 1.51 | 0.73 | 3.2 | -6.67 | 6.18 |
Issuance of Common Stock | - | - | 1.26 | 4.59 | - |
Repurchase of Common Stock | - | -0.16 | -0.16 | -0.41 | - |
Other Financing Activities | 0.21 | - | - | - | -1.13 |
Financing Cash Flow | 1.72 | 0.57 | 4.3 | -2.5 | 5.06 |
Net Cash Flow | -0.82 | 3.78 | 0.44 | -0.76 | 1.74 |
Free Cash Flow | -2.66 | 4.18 | -3.48 | 1.9 | 1.61 |
Free Cash Flow Growth | - | - | - | 17.72% | - |
Free Cash Flow Margin | -3.48% | 6.20% | -5.84% | 3.12% | 2.71% |
Free Cash Flow Per Share | - | - | -0.49 | - | 0.26 |
Cash Interest Paid | - | 4.84 | 3.29 | 2.11 | 2.13 |
Cash Income Tax Paid | - | 0.09 | 0.05 | 0.13 | 1.08 |
Levered Free Cash Flow | -0.39 | 5.86 | -1.92 | 0.59 | -0.57 |
Unlevered Free Cash Flow | 3.3 | 8.89 | 0.14 | 1.9 | 0.76 |
Change in Working Capital | -2.31 | 3.1 | -1.58 | 4.32 | 1.69 |